Cruz-Nocelo EJ, Serratos-Vázquez MC, Pérez-Atanasio JM, Luján-Olivar F, Zúñiga-Carmona VH

Language: Spanish
References: 24
Page: 237-244
PDF size: 231.76 Kb.

ABSTRACT

Introduction: Multimodal analgesia associated to adjuvants like intravenous lidocaine is the current recommendation for postoperative pain in burned patients. The aim was to compare the intensity of postoperative pain in burned patients treated with multimodal analgesia with and without intravenous lidocaine. Material and methods: An observational study was performed in postoperative pain through the Visual Analogic Scale registered in records of burned patients to compare three schemes of multimodal analgesia: Non-lidocaine group, Intraoperative lidocaine group and Postoperative lidocaine group. Results: When comparing Intraoperative lidocaine group versus the Postoperative lidocaine group, the first one found lower pain intensity at all times of the records, but the difference was statistically significant in background pain (p = 0.01), at 24 hours (p = 0.002), 32 hours (p = 0.03), 40 hours (p = 0.002), 48 hours (p = 0.003), 56 hours (p = 0.002), 72 hours (p = 0.03), at the first (p = 0.02), second (p = 0.002) and the third postoperative day (p = 0.01). Conclusions: Burned patients treated with intravenous lidocaine infusion during surgery at dose of 2 mg/kg ideal body weight/hour as a component of a multimodal analgesia scheme presented lower intensity of postoperative pain.

REFERENCES

1. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD. Burn injury pain: the continuing challenge. J Pain. 2007;8:533-548.

2. Richardson P, Mustard L. The management of pain in the burns unit. Burns. 2009, pp. 921-936.

3. McIntyre MK, Clifford JL, Maani CV, Burmeister DM. Progress of clinical practice on the management of burn-associated pain: Lessons from animal models. Burns. 2016;42:1161-1172.

4. Gamst-Jensen H, Nygaard Vedel P, Lindberg-Larsen VO, Egerod I. Acute pain management in burn patients: Appraisal and thematic analysis of four clinical guidelines. Burns. 2014;40:1463-1469.

5. Wasiak J, Mahar PD, McGuinness SK, Spinks A, Danilla S, Cleland H, et al. Intravenous lidocaine for the treatment of background or procedural burn pain. Cochrane Database Syst Rev. 2014; 10: CD005622.

6. McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery. Drugs. 2010;70:1149-1163.

7. Kranke P, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015;7:CD009642.

8. Chang YC, Liu CL, Liu TP, Yang PS, Chen MJ, Cheng SP. Effect of perioperative intravenous lidocaine infusion on acute and chronic pain after breast surgery: a meta-analysis of randomized controlled trials. Pain Pract. 2017;17:336-343.

9. Wasiak J, Spinks A, Costello V, Ferraro F, Paul E, Konstantatos A, Cleland H. Adjuvant use of intravenous lidocaine for procedural burn pain relief: A randomized double-blind, placebo-controlled, cross-over trial. Burns. 2011;37:951-957.

10. Weibel S, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Eberhart LH, et al. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth. 2016;116:770-783.

11. Gibbons K, DeMonbrun A, Beckman EJ, Keefer P, Wagner D, Stewart M, et al. Continuous lidocaine infusions to manage opioid-refractory pain in a series of cancer patients in a pediatric hospital. Pediatr Blood Cancer. 2016;63:1168-1174.

12. Przeklasa-Muszyńska A, Kocot-Kępska, Dobrogowski J, Wiatr M, Mika J. Intravenous lidocaine infusions in a multidirectional model of treatment of neuropathic pain patients. Pharmacol Rep. 2016;68:1069-1075.

13. Finnerup NB, Biering-Sørensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, et al. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology. 2005;102:1023-1030.

14. Samimi S, Taheri A, Davari Tanha F. Comparison between intraperitoneal and intravenous lidocaine for postoperative analgesia after elective abdominal hysterectomy, a double-blind placebo controlled study. J Family Reprod Health. 2015;9:193-198.

15. Couceiro TC, Lima LC, Burle LM, Valença MM. Intravenous lidocaine for postmastectomy pain treatment: randomized, blind, placebo controlled clinical trial. Braz J Anesthesiol. 2015;65:207-212.

16. Harbin KR, Norris TE. Anesthetic management of patients with major burn injury. AANA J. 2012;80:430-439.

17. Retrouvey H, Shahrokhi S. Pain and the thermally injured patient- a review of current therapies. J Burn Care Res. 2015;36:351-323.

18. Corry NH, Klick B, Fauerbach JA. Posttraumatic stress disorder and pain impact functioning and disability after major burn injury. J Burn Care Res. 2010;31:13-25.

19. Dauber A, Osgood PF, Breslau AJ, Vernon HL, Carr DB. Chronic persistent pain after severe burns: A survey of 358 burn survivors. Pain Med. 2002;3:6-17.

20. Feizerfan A, Sheh G. Transition from acute to chronic pain. Continuing Education in Anaesthesia, Critical Care & Pain. 2015;2:98-102.

21. Muth-Selbach U, Hermanns H, Stegmann JU, Kollosche K, Freynhagen R, Bauer I, Lipfert P. Antinociceptive effects of systemic lidocaine: Involvement of spinal glycinergic system. Eur J Pharmacol. 2009;613:68-73.

22. Werdehausen R, Mittnacht S, Bee LA, Minett MS, Armbruster A, Bauer I, et al. The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain. Pain. 2015;156:1647-1659.

23. De Oliveira CM, Issy AM, Sakata RK. Intraoperative Intravenous Lidocaine. Rev Bras Anestesiol. 2010;60:325-333.

24. De Castro RJ, Leal PC, Sakata RK. Pain Management in burn patients. Rev Bras Anestesiol. 2013;63:149-153.